Pharmacometrics: Opportunity for reducing disease burden in the developing world: The case of Africa

22Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pharmacometricians are virtually nonexistent in Africa and the developing world. The unrelenting burden of infectious diseases, which are often treated using medicines with narrow effectiveness and safety dose ranges, and the growing prevalence and recognition of non-communicable diseases represent significant threats for the patients, although affording an opportunity for advancing science. This article outlines the case for pharmacometricians to redirect their expertise to focus on the disease burden affecting the developing world. © 2013 ASCPT All rights reserved.

Cite

CITATION STYLE

APA

Pillai, G., Davies, G., Denti, P., Steimer, J. L., McIlleron, H., Zvada, S., … Holford, N. H. G. (2013). Pharmacometrics: Opportunity for reducing disease burden in the developing world: The case of Africa. CPT: Pharmacometrics and Systems Pharmacology, 2(8). https://doi.org/10.1038/psp.2013.45

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free